Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 20, Issue 11

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 20, Issue 11 (2021)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 20, Issue 11 (2021)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Volume 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Drug safety evaluation

Article

OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation

Fan Cheng & Fayyaz Ahmed

Pages: 1275-1289

Published online: 05 Jul 2021

AbstractforOnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation | Full Text | References | PDF (333.7 KB) | EPUB

2738 Views
6 CrossRef citations
0Altmetric

Open Access

Article

Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain

Hon Sen Tan & Ashraf S. Habib

Pages: 1291-1298

Published online: 20 Aug 2021

AbstractforSafety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain | Full Text | References | PDF (305.3 KB) | EPUB

287 Views
2 CrossRef citations
0Altmetric

Article

Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness

Ashesha Mechineni, Hagar Kassab & Rajapriya Manickam

Pages: 1299-1307

Published online: 16 Aug 2021

AbstractforRemdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness | Full Text | References | PDF (471.9 KB) | EPUB

307 Views
8 CrossRef citations
0Altmetric

Special report

Article

The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism

Yajnavalka Banerjee, Anca Pantea Stoian, José Silva-Nunes, Alper Sonmez, Ali A. Rizvi, Andrej Janez & Manfredi Rizzo

Pages: 1309-1315

Published online: 25 Aug 2021

AbstractforThe role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism | Full Text | References | PDF (1.4 MB) | EPUB

1902 Views
10 CrossRef citations
0Altmetric

Review

Article

Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV

Arturo Ciccullo, Gianmaria Baldin, Cristina Putaggio, Simona Di Giambenedetto & Alberto Borghetti

Pages: 1317-1332

Published online: 27 May 2021

AbstractforComparative safety review of recommended, first-line single-tablet regimens in patients with HIV | Full Text | References | PDF (423.9 KB) | EPUB

567 Views
3 CrossRef citations
0Altmetric

Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency

Andrea Galassi, Paola Ciceri, Giulia Porata, Rossella Iatrino, Giulia Boni Brivio, Eliana Fasulo, Lorenza Magagnoli, Andrea Stucchi, Michela Frittoli, Anila Cara & Mario Cozzolino

Pages: 1333-1349

Published online: 09 Jun 2021

AbstractforCurrent treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency | Full Text | References | PDF (1.1 MB) | EPUB

328 Views
2 CrossRef citations
0Altmetric

Cardiovascular risks associated with protease inhibitors for the treatment of HIV

Camilla Ingrid Hatleberg, Lene Ryom & Caroline Sabin

Pages: 1351-1366

Published online: 26 Jul 2021

AbstractforCardiovascular risks associated with protease inhibitors for the treatment of HIV | Full Text | References | PDF (1.3 MB) | EPUB

327 Views
3 CrossRef citations
0Altmetric

Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection

Randy M. Stalter, Jillian Pintye & Kenneth K. Mugwanya

Pages: 1367-1373

Published online: 28 May 2021

AbstractforSafety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection | Full Text | References | PDF (348.3 KB) | EPUB

342 Views
2 CrossRef citations
0Altmetric

Antimicrobial resistance and the post antibiotic era: better late than never effort

Prashant Chandra, Unnikrishnan mk, Vandana ke, Chiranjay Mukhopadhyay, Dinesh Acharya U, Surulivel Rajan M & Rajesh V

Pages: 1375-1390

Published online: 22 Jul 2021

AbstractforAntimicrobial resistance and the post antibiotic era: better late than never effort | Full Text | References | PDF (896.3 KB) | EPUB

404 Views
7 CrossRef citations
0Altmetric

Systematic review

Resident and family engagement in medication management in aged care facilities: a systematic review

Elizabeth Manias, Tracey Bucknall, Alison Hutchinson, Briony Dow & Narelle Borrott

Pages: 1391-1409

Published online: 14 Jun 2021

AbstractforResident and family engagement in medication management in aged care facilities: a systematic review | Full Text | References | PDF (1.7 MB) | EPUB

576 Views
3 CrossRef citations
0Altmetric

Meta-analysis

Effect of levosimendan on renal function in background of left ventricular dysfunction: a meta-analysis of randomized trials

Yu-Xiang Long, Di-Yu Cui, Xue Kuang, Yue Hu, Shuang Hu, Chun-Ping Wang & Zeng-Zhang Liu

Pages: 1411-1420

Published online: 10 Jul 2021

121 Views
4 CrossRef citations
0Altmetric

Original research

Article

Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system

Milo Gatti, Michele Fusaroli, Emanuel Raschi, Ugo Moretti, Elisabetta Poluzzi & Fabrizio De Ponti

Pages: 1421-1431

Published online: 19 Jul 2021

AbstractforSerious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system | Full Text | References | PDF (344.3 KB) | EPUB

441 Views
6 CrossRef citations
0Altmetric

Article

Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle – a focus on benefits and risks

Lourens T. Bloem, Mariana Karomi, Jarno Hoekman, Menno E. van der Elst, Hubert G.M. Leufkens, Olaf H. Klungel & Aukje K. Mantel-Teeuwisse

Pages: 1433-1442

Published online: 15 Jul 2021

2161 Views
2 CrossRef citations
0Altmetric

Open Access

Article

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system

Vijay Kumar, Anand Prakash Singh, Nicholas Wheeler, Cristi L. Galindo & Jong-Joo Kim

Pages: 1443-1450

Published online: 26 Jul 2021

AbstractforSafety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system | Full Text | References | PDF (1 MB) | EPUB

400 Views
6 CrossRef citations
0Altmetric

Correspondence

Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines

Maurizio Sessa, Kristian Kragholm, Anders Hviid & Morten Andersen

Pages: 1451-1453

Published online: 26 Jul 2021

AbstractforThromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines | Full Text | References | PDF (165.7 KB) | EPUB

6017 Views
25 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Wenqiang Kong et al.

Article | Published online: 5 Jul 2024

PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database

Xiayang Ren et al.

Article | Published online: 5 Jul 2024

Open Access

A real-world pharmacovigilance study of FDA adverse event reporting system events for atogepant

Heli Wen et al.

Article | Published online: 5 Jul 2024

Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a Network Meta-analysis and Meta-regression

Kannan Sridharan et al.

Review Article | Published online: 5 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.20, Iss.11, 2021)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?